Back to Explorer

CPG Sec. 398.300 Registration of Assemblers of Diagnostic X-Ray Systems as Device Manufacturers

FinalOffice of Regulatory Affairs Center for Devices and Radiological Health02/28/1995

Description

Questions have been raised as to whether an assembler of diagnostic X-ray systems must register as a device manufacturer.

Scope & Applicability

Product Classes

6
Phacofragmentation System device

AC powered device with a fragmenting needle intended for use in cataract surgery; specific device subject to these labeling and sterilization requirements

Class II Device

Devices subject to section 522 postmarket surveillance orders; devices subject to postmarket surveillance orders

Class II medical device

Biological indicators are regulated as class II medical devices

Phacofragmentation System

The primary device type discussed in the guidance.; Device type subject to the review checklist

Combination Product

Products combining drug, device, or biological constituents; Generally recommended for Enhanced Documentation; Requires 14971-based framework incorporating ICH Q9; A drug-device combination where the device constituent part detects ingestion.

Class II

The devices that are the subject of this guidance are Class II non-spinal metallic bone screws and washers

Regulatory Context

Attributes

4
Ultrasonic frequency

The phaco tip is oscillated at about 40,000 hertz.

Single use

Device labeling indicating it is intended for one use only; device labeled for single use only

Sterility assurance level

support the use of the proposed cycle and the desired sterility assurance level

Substantial equivalence

Regulatory standard for 510(k) clearance; demonstration required for 510(k) submission; regulatory standard for 510(k) clearance; Comparison of subject device parameters to predicate 510(k) submission numbers.

Identified Hazards

Hazards

4
Adverse thermal tissue effects

Oscillation generates heat; cooling mechanisms preclude effects

device related risks

Safety information required in the labeling

Non-pyrogenic

Claim that device is free of fever-inducing substances

Collapse of the anterior chamber

Risk caused by excessive vacuum build up

Related CFR Sections (4)

Related Warning Letters (9)

  • Good Laboratory Practice (GLP) for Nonclinical Laboratory Studies

    CCIC Huatongwei International Inspection Co., Ltd.

    2025-08-26
  • Good Laboratory Practice (GLP) for Nonclinical Laboratory Studies

    Jiangsu Kerbio Medical Technology Group Co.

    2025-08-26
  • Investigational Device Exemptions (IDE)/Premarket Approval Application (PMA)

    Mid-Link Testing Company, Ltd

    2024-09-11
  • Investigational Device Exemptions (IDE)/Premarket Approval Application (PMA)

    Sanitation & Environmental Technology Institute dba SDWH

    2024-09-11
  • Good Laboratory Practice (GLP) for Nonclinical Laboratory Studies

    Samm Solutions, Inc., d.b.a. BTS Research

    2023-10-31
  • Bioresearch Monitoring Program

    Valley Biosystems

    2022-08-09
  • Good Laboratory Practice (GLP)

    Toxikon Corporation/Labcorp Bedford LLC

    2022-02-22
  • Good Laboratory Practice (GLP) for Nonclinical Laboratory Studies

    University of Kentucky

    2020-05-05
  • Good Laboratory Practice (GLP) for Nonclinical Laboratory Studies

    Steiner Biotechnology, LLC

    2020-04-07

See Also (8)